EF1D_HUMAN - dbPTM
EF1D_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID EF1D_HUMAN
UniProt AC P29692
Protein Name Elongation factor 1-delta
Gene Name EEF1D
Organism Homo sapiens (Human).
Sequence Length 281
Subcellular Localization Isoform 2: Nucleus .
Protein Description Isoform 1: EF-1-beta and EF-1-delta stimulate the exchange of GDP bound to EF-1-alpha to GTP, regenerating EF-1-alpha for another round of transfer of aminoacyl-tRNAs to the ribosome.; Isoform 2: Regulates induction of heat-shock-responsive genes through association with heat shock transcription factors and direct DNA-binding at heat shock promoter elements (HSE)..
Protein Sequence MATNFLAHEKIWFDKFKYDDAERRFYEQMNGPVAGASRQENGASVILRDIARARENIQKSLAGSSGPGASSGTSGDHGELVVRIASLEVENQSLRGVVQELQQAISKLEARLNVLEKSSPGHRATAPQTQHVSPMRQVEPPAKKPATPAEDDEDDDIDLFGSDNEEEDKEAAQLREERLRQYAEKKAKKPALVAKSSILLDVKPWDDETDMAQLEACVRSIQLDGLVWGASKLVPVGYGIRKLQIQCVVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNKI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MATNFLAHE
------CCCCCCCCC
15.9622223895
102-HydroxyisobutyrylationTNFLAHEKIWFDKFK
CCCCCCCCHHHHCCC
35.06-
10AcetylationTNFLAHEKIWFDKFK
CCCCCCCCHHHHCCC
35.0626822725
10UbiquitinationTNFLAHEKIWFDKFK
CCCCCCCCHHHHCCC
35.0621890473
10 (in isoform 1)Ubiquitination-35.0621890473
10UbiquitinationTNFLAHEKIWFDKFK
CCCCCCCCHHHHCCC
35.0621890473
12 (in isoform 2)Phosphorylation-13.37-
152-HydroxyisobutyrylationHEKIWFDKFKYDDAE
CCCHHHHCCCCCHHH
33.99-
15AcetylationHEKIWFDKFKYDDAE
CCCHHHHCCCCCHHH
33.9926051181
15UbiquitinationHEKIWFDKFKYDDAE
CCCHHHHCCCCCHHH
33.9921890473
15 (in isoform 1)Ubiquitination-33.9921890473
15UbiquitinationHEKIWFDKFKYDDAE
CCCHHHHCCCCCHHH
33.9921890473
17AcetylationKIWFDKFKYDDAERR
CHHHHCCCCCHHHHH
54.2119608861
17UbiquitinationKIWFDKFKYDDAERR
CHHHHCCCCCHHHHH
54.2119608861
18PhosphorylationIWFDKFKYDDAERRF
HHHHCCCCCHHHHHH
23.3721945579
22UbiquitinationKFKYDDAERRFYEQM
CCCCCHHHHHHHHHH
51.9221890473
24MethylationKYDDAERRFYEQMNG
CCCHHHHHHHHHHCC
29.97-
26NitrationDDAERRFYEQMNGPV
CHHHHHHHHHHCCCC
11.93-
26PhosphorylationDDAERRFYEQMNGPV
CHHHHHHHHHHCCCC
11.9321945579
27UbiquitinationDAERRFYEQMNGPVA
HHHHHHHHHHCCCCC
40.4121890473
29SulfoxidationERRFYEQMNGPVAGA
HHHHHHHHCCCCCCC
4.1228465586
37PhosphorylationNGPVAGASRQENGAS
CCCCCCCCCCCCCCC
33.3121945579
37 (in isoform 3)Phosphorylation-33.3122496350
40 (in isoform 3)Phosphorylation-57.4325159151
41 (in isoform 3)Phosphorylation-42.8928355574
44PhosphorylationSRQENGASVILRDIA
CCCCCCCCHHHHHHH
15.8723401153
46 (in isoform 3)Phosphorylation-2.1230108239
47 (in isoform 3)Phosphorylation-3.6420068231
49 (in isoform 3)Phosphorylation-35.1426552605
50 (in isoform 3)Phosphorylation-1.9527251275
59AcetylationRARENIQKSLAGSSG
HHHHHHHHHHCCCCC
43.5726051181
59UbiquitinationRARENIQKSLAGSSG
HHHHHHHHHHCCCCC
43.5721890473
59 (in isoform 1)Ubiquitination-43.5721890473
60PhosphorylationARENIQKSLAGSSGP
HHHHHHHHHCCCCCC
13.6929255136
64PhosphorylationIQKSLAGSSGPGASS
HHHHHCCCCCCCCCC
26.8923401153
64 (in isoform 4)Phosphorylation-26.8925159151
65PhosphorylationQKSLAGSSGPGASSG
HHHHCCCCCCCCCCC
48.3530278072
70PhosphorylationGSSGPGASSGTSGDH
CCCCCCCCCCCCCCC
34.9023911959
71PhosphorylationSSGPGASSGTSGDHG
CCCCCCCCCCCCCCC
45.6230278072
71 (in isoform 4)Phosphorylation-45.6225627689
73PhosphorylationGPGASSGTSGDHGEL
CCCCCCCCCCCCCCE
31.3321712546
74PhosphorylationPGASSGTSGDHGELV
CCCCCCCCCCCCCEE
45.8323898821
77 (in isoform 2)Phosphorylation-34.8424300666
83AcetylationDHGELVVRIASLEVE
CCCCEEEEEEEEEEC
15.9819608861
83UbiquitinationDHGELVVRIASLEVE
CCCCEEEEEEEEEEC
15.9819608861
83UbiquitinationDHGELVVRIASLEVE
CCCCEEEEEEEEEEC
15.9821890473
86PhosphorylationELVVRIASLEVENQS
CEEEEEEEEEECCCH
23.7730266825
88AcetylationVVRIASLEVENQSLR
EEEEEEEEECCCHHH
45.3419608861
88UbiquitinationVVRIASLEVENQSLR
EEEEEEEEECCCHHH
45.3419608861
91 (in isoform 2)Phosphorylation-41.7518669648
93AcetylationSLEVENQSLRGVVQE
EEEECCCHHHHHHHH
31.4519608861
93PhosphorylationSLEVENQSLRGVVQE
EEEECCCHHHHHHHH
31.4520068231
93UbiquitinationSLEVENQSLRGVVQE
EEEECCCHHHHHHHH
31.4519608861
94 (in isoform 2)Phosphorylation-3.8825159151
95MethylationEVENQSLRGVVQELQ
EECCCHHHHHHHHHH
40.90-
98AcetylationNQSLRGVVQELQQAI
CCHHHHHHHHHHHHH
3.9919608861
98UbiquitinationNQSLRGVVQELQQAI
CCHHHHHHHHHHHHH
3.9919608861
106PhosphorylationQELQQAISKLEARLN
HHHHHHHHHHHHHHH
33.9222617229
107AcetylationELQQAISKLEARLNV
HHHHHHHHHHHHHHH
44.2119608861
107UbiquitinationELQQAISKLEARLNV
HHHHHHHHHHHHHHH
44.2121890473
107 (in isoform 1)Ubiquitination-44.2121890473
107 (in isoform 2)Phosphorylation-44.2125693802
1172-HydroxyisobutyrylationARLNVLEKSSPGHRA
HHHHHHHHCCCCCCC
52.66-
117AcetylationARLNVLEKSSPGHRA
HHHHHHHHCCCCCCC
52.6619608861
117MalonylationARLNVLEKSSPGHRA
HHHHHHHHCCCCCCC
52.6626320211
117SuccinylationARLNVLEKSSPGHRA
HHHHHHHHCCCCCCC
52.66-
117SuccinylationARLNVLEKSSPGHRA
HHHHHHHHCCCCCCC
52.66-
117UbiquitinationARLNVLEKSSPGHRA
HHHHHHHHCCCCCCC
52.6619608861
118PhosphorylationRLNVLEKSSPGHRAT
HHHHHHHCCCCCCCC
32.1825159151
119PhosphorylationLNVLEKSSPGHRATA
HHHHHHCCCCCCCCC
46.0725159151
125PhosphorylationSSPGHRATAPQTQHV
CCCCCCCCCCCCCCC
38.5429255136
129PhosphorylationHRATAPQTQHVSPMR
CCCCCCCCCCCCCCC
21.4229255136
133PhosphorylationAPQTQHVSPMRQVEP
CCCCCCCCCCCCCCC
15.7420201521
135SulfoxidationQTQHVSPMRQVEPPA
CCCCCCCCCCCCCCC
3.4921406390
147PhosphorylationPPAKKPATPAEDDED
CCCCCCCCCCCCCCC
31.4019664994
162PhosphorylationDDIDLFGSDNEEEDK
CCCCCCCCCCHHHHH
29.9019664994
169UbiquitinationSDNEEEDKEAAQLRE
CCCHHHHHHHHHHHH
53.16-
178MethylationAAQLREERLRQYAEK
HHHHHHHHHHHHHHH
30.34-
182PhosphorylationREERLRQYAEKKAKK
HHHHHHHHHHHHCCC
15.4229341593
185AcetylationRLRQYAEKKAKKPAL
HHHHHHHHHCCCCCE
50.2726051181
185SuccinylationRLRQYAEKKAKKPAL
HHHHHHHHHCCCCCE
50.2723954790
185UbiquitinationRLRQYAEKKAKKPAL
HHHHHHHHHCCCCCE
50.27-
186UbiquitinationLRQYAEKKAKKPALV
HHHHHHHHCCCCCEE
57.87-
188UbiquitinationQYAEKKAKKPALVAK
HHHHHHCCCCCEEEC
69.07-
1892-HydroxyisobutyrylationYAEKKAKKPALVAKS
HHHHHCCCCCEEECC
40.14-
189UbiquitinationYAEKKAKKPALVAKS
HHHHHCCCCCEEECC
40.1421906983
196PhosphorylationKPALVAKSSILLDVK
CCCEEECCEEEECCC
16.9325627689
197PhosphorylationPALVAKSSILLDVKP
CCEEECCEEEECCCC
19.2922985185
203AcetylationSSILLDVKPWDDETD
CEEEECCCCCCCCCC
39.8019825591
203SumoylationSSILLDVKPWDDETD
CEEEECCCCCCCCCC
39.80-
208UbiquitinationDVKPWDDETDMAQLE
CCCCCCCCCCHHHHH
44.2121890473
209PhosphorylationVKPWDDETDMAQLEA
CCCCCCCCCHHHHHH
37.7622817901
211SulfoxidationPWDDETDMAQLEACV
CCCCCCCHHHHHHHH
3.1430846556
220PhosphorylationQLEACVRSIQLDGLV
HHHHHHHHHCCCCEE
8.3521712546
225UbiquitinationVRSIQLDGLVWGASK
HHHHCCCCEEECCCC
30.6221890473
231PhosphorylationDGLVWGASKLVPVGY
CCEEECCCCCEEECC
23.6821712546
232UbiquitinationGLVWGASKLVPVGYG
CEEECCCCCEEECCC
53.632189047
232 (in isoform 1)Ubiquitination-53.6321890473
238PhosphorylationSKLVPVGYGIRKLQI
CCCEEECCCEEEEEE
15.0425394399
2422-HydroxyisobutyrylationPVGYGIRKLQIQCVV
EECCCEEEEEEEEEE
42.71-
242UbiquitinationPVGYGIRKLQIQCVV
EECCCEEEEEEEEEE
42.71-
247 (in isoform 2)Phosphorylation-3.8525884760
265UbiquitinationLLEEEITKFEEHVQS
HHHHHHHHHHHHHHH
57.34-
2802-HydroxyisobutyrylationVDIAAFNKI------
CCHHHHCCC------
43.25-
280UbiquitinationVDIAAFNKI------
CCHHHHCCC------
43.25-
376 (in isoform 2)Ubiquitination-21890473
381 (in isoform 2)Ubiquitination-21890473
403Phosphorylation---------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------
27251275
410Phosphorylation----------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------
24719451
425 (in isoform 2)Ubiquitination-21890473
426Phosphorylation--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
27251275
430Phosphorylation------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------
24719451
431Phosphorylation-------------------------------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------------------------------------
27251275
436Phosphorylation------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------------
27251275
437Phosphorylation-------------------------------------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
24719451
452Phosphorylation----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
24719451
473 (in isoform 2)Ubiquitination-21890473
483 (in isoform 2)Ubiquitination--
484Phosphorylation------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
27251275
485Phosphorylation-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
24719451
491Phosphorylation-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
27251275
495Phosphorylation-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
27251275
499Phosphorylation---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
27251275
513Phosphorylation-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
27251275
528Phosphorylation--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
24719451
598 (in isoform 2)Ubiquitination-21890473

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
133SPhosphorylationKinaseCDK1P06493
PSP
162SPhosphorylationKinaseCSNK2A1P68400
GPS
162SPhosphorylationKinaseCK2-FAMILY-GPS
162SPhosphorylationKinaseCK2-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of EF1D_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of EF1D_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EF1G_HUMANEEF1Gphysical
16189514
CD48_HUMANCD48physical
16169070
EF1D_HUMANEEF1Dphysical
16169070
DPYL1_HUMANCRMP1physical
16169070
EF1G_HUMANEEF1Gphysical
16169070
GARS_HUMANGARSphysical
11829477
RL15_HUMANRPL15physical
22939629
RL18_HUMANRPL18physical
22939629
TPR_HUMANTPRphysical
22939629
MCCA_HUMANMCCC1physical
22939629
SF3A3_HUMANSF3A3physical
22939629
FLNC_HUMANFLNCphysical
22939629
TF65_HUMANRELAphysical
21988832
SIAH1_HUMANSIAH1physical
21988832
SIAH2_HUMANSIAH2physical
21988832
SQSTM_HUMANSQSTM1physical
21988832
CAMP2_HUMANCAMSAP2physical
20195357
RHG21_HUMANARHGAP21physical
20195357
ATG7_HUMANATG7physical
20195357
MAP1B_HUMANMAP1Bphysical
20195357
SYEP_HUMANEPRSphysical
20195357
BAG6_HUMANBAG6physical
22863883
OARD1_HUMANOARD1physical
22863883
LMNA_HUMANLMNAphysical
22863883
PSD10_HUMANPSMD10physical
22863883
ZW10_HUMANZW10physical
22863883
EF1D_HUMANEEF1Dphysical
25416956
EF1G_HUMANEEF1Gphysical
25416956
SIAH1_HUMANSIAH1physical
25416956
TCTP_HUMANTPT1physical
25416956
ERP27_HUMANERP27physical
25416956
ACLY_HUMANACLYphysical
26344197
AHNK_HUMANAHNAKphysical
26344197
AKAP8_HUMANAKAP8physical
26344197
DDX46_HUMANDDX46physical
26344197
EF1A1_HUMANEEF1A1physical
26344197
EF1B_HUMANEEF1B2physical
26344197
EF1G_HUMANEEF1Gphysical
26344197
T2FA_HUMANGTF2F1physical
26344197
HCFC1_HUMANHCFC1physical
26344197
HNRPK_HUMANHNRNPKphysical
26344197
HSPB1_HUMANHSPB1physical
26344197
PCBP1_HUMANPCBP1physical
26344197
RTN4_HUMANRTN4physical
26344197
STMN1_HUMANSTMN1physical
26344197
SPT5H_HUMANSUPT5Hphysical
26344197
SYVC_HUMANVARSphysical
26344197
ABTB1_HUMANABTB1physical
21516116
SYCC_HUMANCARSphysical
28514442
MCE1_HUMANRNGTTphysical
28514442
ATP23_HUMANXRCC6BP1physical
28514442
SYVC_HUMANVARSphysical
28514442
KTN1_HUMANKTN1physical
28514442
EF1B_HUMANEEF1B2physical
28514442
ANGE2_HUMANANGEL2physical
28514442
RRBP1_HUMANRRBP1physical
28514442
HASP_HUMANGSG2physical
28514442
SAHH3_HUMANAHCYL2physical
28514442
VWA8_HUMANVWA8physical
28514442
C1QBP_HUMANC1QBPphysical
28514442
TBB8_HUMANTUBB8physical
28514442
CR025_HUMANC18orf25physical
28514442
MAP1B_HUMANMAP1Bphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of EF1D_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-133; THR-147 AND SER-162, AND MASSSPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17; LYS-107 AND LYS-117, ANDMASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Unbiased functional proteomics strategy for protein kinase inhibitorvalidation and identification of bona fide protein kinase substrates:application to identification of as a substrate for CK2.";
Gyenis L., Duncan J.S., Turowec J.P., Bretner M., Litchfield D.W.;
J. Proteome Res. 10:4887-4901(2011).
Cited for: PHOSPHORYLATION AT SER-162 BY CK2.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-129; SER-133 ANDSER-162, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-133; THR-147 AND SER-162, AND MASSSPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; THR-147 ANDSER-162, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; THR-147 ANDSER-162, AND MASS SPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-119; THR-129;SER-133; THR-147 AND SER-162, AND MASS SPECTROMETRY.
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction.";
Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
Mol. Cell. Proteomics 6:1952-1967(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY.
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline.";
Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
Electrophoresis 28:2027-2034(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133 AND SER-162, ANDMASS SPECTROMETRY.
"Phosphoproteomic analysis of the human pituitary.";
Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
Pituitary 9:109-120(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; THR-147 ANDSER-162, AND MASS SPECTROMETRY.
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC.";
Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.;
Proteomics 5:3589-3599(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND MASSSPECTROMETRY.

TOP